Use of hmg-coa reductase inhibitors for treating seborrhea

摘要

The invention concerns a cosmetic composition comprising as active principle, in a physiologically acceptable medium, at least an efficient amount of a HMG-CoA-reductase and at least another active principle capable of completing the effect of the HMG-CoA-reductase for treating seborrhea and related dermatoses, in particular seborrheic dermatitis, black spots and/or comedones.